NEW YORK (GenomeWeb) – Protagen said today it is collaborating with Germany's National Center for Tumor Diseases (NCT) and NEC Laboratories Europe to improve approaches for in silico prediction of immunotherapy response in patients with malignant melanoma.

Under the collaboration, the parties will use machine learning approaches to develop biomarker models for immunotherapy endpoints, including adverse effects, clinical response, and survival.

Financial and other terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Nov
15
Sponsored by
Twist Bioscience

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.